Scheme

WhiteOak Capital Pharma and Healthcare Fund

Holds 50 companies worth ₹841 Cr in Sept 2026.

Fund house
WhiteOakThe fund house that runs this scheme.
AUM
₹927 CrWhiteOak Capital Pharma and Healthcare Fund's AUM at the end of 30 Sept 2026, as AMFI reports it. Up 2.7% on Aug 2026, ₹902 Cr.
Largest holding
Divi s Laboratories LimitedDivi s Laboratories Limited is 8.4% of this scheme's NAV.
Fund manager
Dheeresh PathakRuns its co-manager part since 6 Feb 2024, as the fund house dates it. With Piyush Baranwal (co-manager), Ramesh Mantri (co-manager), Trupti Agrawal (co-manager), Ashish Agrawal (arbitrage).

Holdings^{(Feb 2024 – Sept 2026)}

Holdings in Sept 2026. Tick up to 2 to plot them.
Plot	50 companies ·	₹ Cr
	Divi s Laboratories Limited	77.5
	Sun Pharmaceutical Ind Ltd	65.9
	Torrent Pharmaceuticals Limited	58
	Laurus Labs Limited	36.2
	Apollo Hospitals Enterprise Limited	34.8
	Cipla	34.1
	Sai Life Sciences Limited	30.4
	IPCA Laboratories Limited	26.7
	Cadila Healthcare	26.1
	Neuland Laboratories Limited	24.1
	Dr Lal Path Labs Limited	21.8
	Corona Remedies Limited	21.6
	Thyrocare Technologies Ltd	21.1
	Aurobindo Pharma	19.4
	Ajanta Pharmaceuticals Limited	18.6
	Krishna Institute of Medical Science Ltd	17.1
	Max Healthcare Institute Limited	17.1
	Shaily Engineering Plastics Limited	17
	Global Health Limited	16.9
	Narayana Hrudayalaya Limited	14.9
	Anthem Biosciences Limited	14.6
	Vijaya Diagnostic Centre Limited	14.4
	Onesource Speciality Pharma Ltd	14.4
	Acutaas Chemicals Limited	13.5
	Navin Flourine International Ltd	13.1
	Fortis Healthcare Limited	12.6
	Aarti Pharmalabs Limited	11.2
	Mankind Pharma Limited	11.1
	Procter Gamble Health Limited	10.9
	Molbio Diagnostics Limited	10.7
	Rainbow Children s Medicare Limited	10.6
	Piramal Pharma Limited	9.8
	Aether Industries Limited	9.7
	Kovai Medical Center and Hospital Limited	8.8
	Gland Pharma Limited	8.6
	Senores Pharmaceuticals Limited	7.4
	Jupiter Life Line Hospitals Limited	6.8
	Supriya Lifescience Limited	6.4
	Vimta Labs Limited	6.2
	Innova Captab Limited	5.9
	Nephrocare Health Services Ltd	5.3
	Manipal Health Enterprises Ltd	4.8
	Sudeep Pharma Limited	4.2
	Biocon	3.9
	Tatva Chintan Pharma Chem Limited	3.9
	Orchid Pharma Limited	3.8
	Zota Health Care Limited	3.7
	Novartis India Ltd	2.3
	Laxmi Dental Limited	2.1
	Bharat Parenterals Limited	0.9

Divi s Laboratories Limited
Sun Pharmaceutical Ind Ltd

Market value of each ticked company in WhiteOak Capital Pharma and Healthcare Fund, ₹ crore. Month end. Source: AMC monthly portfolio disclosures.
Month	Divi s Laboratories Limited	Sun Pharmaceutical Ind Ltd
Sept 2025	₹12.3 Cr	₹30.1 Cr
Oct 2025	₹33 Cr	₹37.5 Cr
Nov 2025	₹16.7 Cr	₹41.7 Cr
Dec 2025	₹22.9 Cr	₹55.5 Cr
Jan 2026	₹26.9 Cr	₹52.7 Cr
Feb 2026	₹25.3 Cr	₹63.2 Cr
Mar 2026	₹29.6 Cr	₹68.7 Cr
Apr 2026	₹24.8 Cr	₹63.1 Cr
May 2026	₹21.9 Cr	₹63.5 Cr
Jun 2026	₹12.5 Cr	₹64.2 Cr
Jul 2026	₹31.9 Cr	₹70.3 Cr
Aug 2026	₹76.2 Cr	₹66.7 Cr
Sept 2026	₹77.5 Cr	₹65.9 Cr

Fig. 1.Market value of each ticked company in WhiteOak Capital Pharma and Healthcare Fund, ₹ crore. Month end. Source: AMC monthly portfolio disclosures.

Allocation^{(Sept 2026)}

Market cap

		% of NAV
Large Cap	5	29.16

Mid Cap	11	21.70

Small Cap	32	38.19

Unlisted	2	1.67

Cash & others		9.28

Sectors

Companies

Fig. 2.This scheme's holdings, by market cap, by sector and by company. Hover a slice or a row; click a slice to open it.

Buying and selling, month by month^{(Oct 2025 – Sept 2026)}

Buying and selling, month by month. Change in market value since the previous month, ₹ crore. Month end. Source: AMC monthly portfolio disclosures.

Fig. 3.Change in market value since the previous month, ₹ crore. Month end. Source: AMC monthly portfolio disclosures.

Portfolio^{(Sept 2026)}

Every holding in Sept 2026: its shares, market value (₹ crore) and % of NAV. Month end. Source: AMC monthly portfolio disclosures. Click a column's header to sort by it.

Divi s Laboratories Limited	Equity	Pharmaceuticals & Biotechnology	83.4K	77.5	8.36
Sun Pharmaceutical Ind Ltd	Equity	Pharmaceuticals & Biotechnology	3.63L	65.9	7.11
Torrent Pharmaceuticals Limited	Equity	Pharmaceuticals & Biotechnology	1.21L	58	6.26
Laurus Labs Limited	Equity	Pharmaceuticals & Biotechnology	1.83L	36.2	3.91
Apollo Hospitals Enterprise Limited	Equity	Healthcare Services	42.6K	34.8	3.75
Cipla	Equity	Pharmaceuticals & Biotechnology	2.53L	34.1	3.68
Sai Life Sciences Limited	Equity	Pharmaceuticals & Biotechnology	1.99L	30.4	3.28
IPCA Laboratories Limited	Equity	Pharmaceuticals & Biotechnology	1.38L	26.7	2.88
Cadila Healthcare	Equity	Pharmaceuticals & Biotechnology	2.24L	26.1	2.81
Neuland Laboratories Limited	Equity	Pharmaceuticals & Biotechnology	11.3K	24.1	2.60
Dr Lal Path Labs Limited	Equity	Healthcare Services	1.1L	21.8	2.35
Corona Remedies Limited	Equity	Pharmaceuticals & Biotechnology	1.03L	21.6	2.34
Thyrocare Technologies Ltd	Equity	Healthcare Services	3.95L	21.1	2.27
Aurobindo Pharma	Equity	Pharmaceuticals & Biotechnology	1.16L	19.4	2.09
Ajanta Pharmaceuticals Limited	Equity	Pharmaceuticals & Biotechnology	51.5K	18.6	2.01
Krishna Institute of Medical Science Ltd	Equity	Healthcare Services	2.29L	17.1	1.85
Max Healthcare Institute Limited	Equity	Healthcare Services	1.84L	17.1	1.84
Shaily Engineering Plastics Limited	Equity	Consumer Durables	55.5K	17	1.84
Global Health Limited	Equity	Healthcare Services	1.23L	16.9	1.82
Narayana Hrudayalaya Limited	Equity	Healthcare Services	83.4K	14.9	1.61
Anthem Biosciences Limited	Equity	Pharmaceuticals & Biotechnology	1.7L	14.6	1.57
Vijaya Diagnostic Centre Limited	Equity	Healthcare Services	1L	14.4	1.56
Onesource Speciality Pharma Ltd	Equity	Pharmaceuticals & Biotechnology	94.4K	14.4	1.55
Acutaas Chemicals Limited	Equity	Pharmaceuticals & Biotechnology	41.1K	13.5	1.45
Navin Flourine International Ltd	Equity	Chemicals & Petrochemicals	15.9K	13.1	1.41
Fortis Healthcare Limited	Equity	Healthcare Services	1.64L	12.6	1.36
Aarti Pharmalabs Limited	Equity	Pharmaceuticals & Biotechnology	1.17L	11.2	1.20
Mankind Pharma Limited	Equity	Pharmaceuticals & Biotechnology	44.4K	11.1	1.20
Procter Gamble Health Limited	Equity	Pharmaceuticals & Biotechnology	19.6K	10.9	1.18
Molbio Diagnostics Limited	Equity	Healthcare Equipment & Supplies	81.5K	10.7	1.15
Rainbow Children s Medicare Limited	Equity	Healthcare Services	80.8K	10.6	1.15
Piramal Pharma Limited	Equity	Pharmaceuticals & Biotechnology	4.75L	9.8	1.06
Aether Industries Limited	Equity	Chemicals & Petrochemicals	57.2K	9.7	1.05
Kovai Medical Center and Hospital Limited	Equity	Healthcare Services	14.7K	8.8	0.95
Gland Pharma Limited	Equity	Pharmaceuticals & Biotechnology	29.7K	8.6	0.93
Senores Pharmaceuticals Limited	Equity	Pharmaceuticals & Biotechnology	53.7K	7.4	0.80
Jupiter Life Line Hospitals Limited	Equity	Healthcare Services	2.67L	6.8	0.73
Supriya Lifescience Limited	Equity	Pharmaceuticals & Biotechnology	67.6K	6.4	0.69
Vimta Labs Limited	Equity	Healthcare Services	1.03L	6.2	0.67
Innova Captab Limited	Equity	Pharmaceuticals & Biotechnology	50.7K	5.9	0.63
Nephrocare Health Services Ltd	Equity	Healthcare Services	80.5K	5.3	0.57
Manipal Health Enterprises Ltd	Equity	Healthcare Services	67.8K	4.8	0.52
Sudeep Pharma Limited	Equity	Pharmaceuticals & Biotechnology	35.1K	4.2	0.46
Biocon	Equity	Pharmaceuticals & Biotechnology	1.05L	3.9	0.42
Tatva Chintan Pharma Chem Limited	Equity	Chemicals & Petrochemicals	21.6K	3.9	0.42
Orchid Pharma Limited	Equity	Pharmaceuticals & Biotechnology	37.7K	3.8	0.41
Zota Health Care Limited	Equity	Pharmaceuticals & Biotechnology	28.8K	3.7	0.40
Novartis India Ltd	Equity	Pharmaceuticals & Biotechnology	11.7K	2.3	0.24
Laxmi Dental Limited	Equity	Healthcare Equipment & Supplies	1.11L	2.1	0.23
Bharat Parenterals Limited	Equity	Pharmaceuticals & Biotechnology	5.05K	0.9	0.10

Fig. 4.Every holding in Sept 2026: its shares, market value (₹ crore) and % of NAV. Month end. Source: AMC monthly portfolio disclosures.